{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:41:37Z","timestamp":1784868097920,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T00:00:00Z","timestamp":1378339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1007\/s11064-013-1137-6","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T04:55:38Z","timestamp":1378270538000},"page":"2287-2294","source":"Crossref","is-referenced-by-count":22,"title":["Selegiline Reverses A\u03b225\u201335-Induced Cognitive Deficit in Male Mice"],"prefix":"10.1007","volume":"38","author":[{"given":"Andr\u00e9ia M.","family":"Pazini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme M.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jardel G.","family":"Villarinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francielle","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P. O.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel A.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"key":"1137_CR1","doi-asserted-by":"crossref","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9 (1):63\u201375 e62","DOI":"10.1016\/j.jalz.2012.11.007"},{"issue":"1","key":"1137_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/S1041610210000025","volume":"23","author":"A Comas-Herrera","year":"2011","unstructured":"Comas-Herrera A, Northey S, Wittenberg R, Knapp M, Bhattacharyya S, Burns A (2011) Future costs of dementia-related long-term care: exploring future scenarios. Int Psychogeriatr 23(1):20\u201330","journal-title":"Int Psychogeriatr"},{"issue":"12 Suppl 3","key":"1137_CR3","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1212\/WNL.64.12_suppl_3.S34","volume":"64","author":"AK Desai","year":"2005","unstructured":"Desai AK, Grossberg GT (2005) Diagnosis and treatment of Alzheimer\u2019s disease. Neurology 64(12 Suppl 3):S34\u2013S39","journal-title":"Neurology"},{"key":"1137_CR4","unstructured":"Doody RS (2005) Refining treatment guidelines in Alzheimer\u2019s disease. Geriatr Suppl: 14\u201320"},{"issue":"4","key":"1137_CR5","first-page":"228","volume":"19","author":"LY Fan","year":"2010","unstructured":"Fan LY, Chiu MJ (2010) Pharmacological treatment for Alzheimer\u2019s disease: current approaches and future strategies. Acta Neurol Taiwan 19(4):228\u2013245","journal-title":"Acta Neurol Taiwan"},{"issue":"7 Suppl 2","key":"1137_CR6","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1212\/WNL.63.7_suppl_2.S13","volume":"63","author":"P Jenner","year":"2004","unstructured":"Jenner P (2004) Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson\u2019s disease. Neurology 63(7 Suppl 2):S13\u2013S22","journal-title":"Neurology"},{"issue":"4","key":"1137_CR7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mds.20036","volume":"19","author":"CH Waters","year":"2004","unstructured":"Waters CH, Sethi KD, Hauser RA, Molho E, Bertoni JM (2004) Zydis selegiline reduces off time in Parkinson\u2019s disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study. Mov Disord 19(4):426\u2013432","journal-title":"Mov Disord"},{"issue":"7","key":"1137_CR8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1212\/01.wnl.0000215250.82576.87","volume":"66","author":"R Pahwa","year":"2006","unstructured":"Pahwa R, Factor SA, Lyons KE, Ondo WG, Gronseth G, Bronte-Stewart H, Hallett M, Miyasaki J, Stevens J, Weiner WJ (2006) Practice parameter: treatment of parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66(7):983\u2013995","journal-title":"Neurology"},{"issue":"4","key":"1137_CR9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrn1883","volume":"7","author":"MB Youdim","year":"2006","unstructured":"Youdim MB, Edmondson D, Tipton KF (2006) The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci 7(4):295\u2013309","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"1137_CR10","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jnr.490270419","volume":"27","author":"KJ Reinikainen","year":"1990","unstructured":"Reinikainen KJ, Soininen H, Riekkinen PJ (1990) Neurotransmitter changes in Alzheimer\u2019s disease: implications to diagnostics and therapy. J Neurosci Res 27(4):576\u2013586","journal-title":"J Neurosci Res"},{"issue":"7","key":"1137_CR11","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archneur.1991.00530190064017","volume":"48","author":"DL Sparks","year":"1991","unstructured":"Sparks DL, Woeltz VM, Markesbery WR (1991) Alterations in brain monoamine oxidase activity in aging, Alzheimer\u2019s disease, and pick\u2019s disease. Arch Neurol 48(7):718\u2013721","journal-title":"Arch Neurol"},{"issue":"1","key":"1137_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0306-4522(94)90311-5","volume":"62","author":"J Saura","year":"1994","unstructured":"Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, Loffler J, Richards JG (1994) Increased monoamine oxidase B activity in plaque-associated astrocytes of alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62(1):15\u201330","journal-title":"Neuroscience"},{"issue":"17","key":"1137_CR13","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","volume":"336","author":"M Sano","year":"1997","unstructured":"Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u2019s disease. the Alzheimer\u2019s disease cooperative study. N Engl J Med 336(17):1216\u20131222","journal-title":"N Engl J Med"},{"issue":"2","key":"1137_CR14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0197-4580(00)00100-7","volume":"21","author":"T Thomas","year":"2000","unstructured":"Thomas T (2000) Monoamine oxidase-B inhibitors in the treatment of Alzheimer\u2019s disease. Neurobiol Aging 21(2):343\u2013348","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1137_CR15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gps.545","volume":"17","author":"GK Wilcock","year":"2002","unstructured":"Wilcock GK, Birks J, Whitehead A, Evans SJ (2002) The effect of selegiline in the treatment of people with Alzheimer\u2019s disease: a meta-analysis of published trials. Int J Geriatr Psychiatry 17(2):175\u2013183","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"1137_CR16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","volume":"12","author":"TJ Haley","year":"1957","unstructured":"Haley TJ, McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12(1):12\u201315","journal-title":"Br J Pharmacol Chemother"},{"key":"1137_CR17","doi-asserted-by":"crossref","unstructured":"Antunes M, Biala G The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process 13 (2):93\u2013110","DOI":"10.1007\/s10339-011-0430-z"},{"issue":"6","key":"1137_CR18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.npp.1301256","volume":"32","author":"D Wang","year":"2007","unstructured":"Wang D, Noda Y, Zhou Y, Mouri A, Mizoguchi H, Nitta A, Chen W, Nabeshima T (2007) The allosteric potentiation of nicotinic acetylcholine receptors by galantamine ameliorates the cognitive dysfunction in beta amyloid25-35 i.c.v.-injected mice: involvement of dopaminergic systems. Neuropsychopharmacology 32(6):1261\u20131271","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1137_CR19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1096\/fj.02-0448fje","volume":"17","author":"T Nagai","year":"2003","unstructured":"Nagai T, Yamada K, Kim HC, Kim YS, Noda Y, Imura A, Nabeshima Y, Nabeshima T (2003) Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. Faseb J 17(1):50\u201352","journal-title":"Faseb J"},{"issue":"1","key":"1137_CR20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biopsych.2005.06.006","volume":"59","author":"H Kamei","year":"2006","unstructured":"Kamei H, Nagai T, Nakano H, Togan Y, Takayanagi M, Takahashi K, Kobayashi K, Yoshida S, Maeda K, Takuma K, Nabeshima T, Yamada K (2006) Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1\/2 activation in the prefrontal cortex of mice. Biol Psychiatry 59(1):75\u201384","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1137_CR21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.nlm.2008.06.010","volume":"90","author":"B Roozendaal","year":"2008","unstructured":"Roozendaal B, Castello NA, Vedana G, Barsegyan A, McGaugh JL (2008) Noradrenergic activation of the basolateral amygdala modulates consolidation of object recognition memory. Neurobiol Learn Mem 90(3):576\u2013579","journal-title":"Neurobiol Learn Mem"},{"issue":"2","key":"1137_CR22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0009-9120(85)80094-1","volume":"18","author":"T Matsumoto","year":"1985","unstructured":"Matsumoto T, Suzuki O, Furuta T, Asai M, Kurokawa Y, Nimura Y, Katsumata Y, Takahashi I (1985) A sensitive fluorometric assay for serum monoamine oxidase with kynuramine as substrate. Clin Biochem 18(2):126\u2013129","journal-title":"Clin Biochem"},{"issue":"2","key":"1137_CR23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bmcl.2008.03.001","volume":"19","author":"S Sant\u2019 Anna Gda","year":"2009","unstructured":"Sant\u2019 Anna Gda S, Machado P, Sauzem PD, Rosa FA, Rubin MA, Ferreira J, Bonacorso HG, Zanatta N, Martins MA (2009) Ultrasound promoted synthesis of 2-imidazolines in water: a greener approach toward monoamine oxidase inhibitors. Bioorg Med Chem Lett 19(2):546\u2013549","journal-title":"Bioorg Med Chem Lett"},{"issue":"1\u20133","key":"1137_CR24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2012.06.042","volume":"690","author":"JG Villarinho","year":"2012","unstructured":"Villarinho JG, Oliveira SM, Silva CR, Cabreira TN, Ferreira J (2012) Involvement of monoamine oxidase B on models of postoperative and neuropathic pain in mice. Eur J Pharmacol 690(1\u20133):107\u2013114","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1137_CR25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bbr.2008.03.002","volume":"190","author":"H Tsunekawa","year":"2008","unstructured":"Tsunekawa H, Noda Y, Mouri A, Yoneda F, Nabeshima T (2008) Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25\u201335). Behav Brain Res 190(2):224\u2013232","journal-title":"Behav Brain Res"},{"issue":"2\u20133","key":"1137_CR26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2005.06.024","volume":"518","author":"K Takahata","year":"2005","unstructured":"Takahata K, Minami A, Kusumoto H, Shimazu S, Yoneda F (2005) Effects of selegiline alone or with donepezil on memory impairment in rats. Eur J Pharmacol 518(2\u20133):140\u2013144","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"1137_CR27","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.exger.2005.03.004","volume":"40","author":"MN Lima de","year":"2005","unstructured":"de Lima MN, Laranja DC, Caldana F, Bromberg E, Roesler R, Schroder N (2005) Reversal of age-related deficits in object recognition memory in rats with l-deprenyl. Exp Gerontol 40(6):506\u2013511","journal-title":"Exp Gerontol"},{"issue":"3","key":"1137_CR28","first-page":"234","volume":"24","author":"V Filip","year":"1999","unstructured":"Filip V, Kolibas E (1999) Selegiline in the treatment of Alzheimer\u2019s disease: a long-term randomized placebo-controlled trial. Czech and slovak senile dementia of alzheimer type study group. J Psychiatry Neurosci 24(3):234\u2013243","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"1137_CR29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of alzheimer-related changes. Acta Neuropathol 82(4):239\u2013259","journal-title":"Acta Neuropathol"},{"issue":"6","key":"1137_CR30","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1212\/WNL.52.6.1158","volume":"52","author":"A Delacourte","year":"1999","unstructured":"Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer\u2019s disease. Neurology 52(6):1158\u20131165","journal-title":"Neurology"},{"issue":"4","key":"1137_CR31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00008877-199708000-00006","volume":"8","author":"L Bevilaqua","year":"1997","unstructured":"Bevilaqua L, Ardenghi P, Schroder N, Bromberg E, Schmitz PK, Schaeffer E, Quevedo J, Bianchin M, Walz R, Medina JH, Izquierdo I (1997) Drugs acting upon the cyclic adenosine monophosphate\/protein kinase a signalling pathway modulate memory consolidation when given late after training into rat hippocampus but not amygdala. Behav Pharmacol 8(4):331\u2013338","journal-title":"Behav Pharmacol"},{"issue":"9","key":"1137_CR32","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1073\/pnas.96.9.5280","volume":"96","author":"ME Bach","year":"1999","unstructured":"Bach ME, Barad M, Son H, Zhuo M, Lu YF, Shih R, Mansuy I, Hawkins RD, Kandel ER (1999) Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc Natl Acad Sci U S A 96(9):5280\u20135285","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1137_CR33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jnr.10148","volume":"67","author":"M Ebadi","year":"2002","unstructured":"Ebadi M, Sharma S, Shavali S, El Refaey H (2002) Neuroprotective actions of selegiline. J Neurosci Res 67(3):285\u2013289","journal-title":"J Neurosci Res"},{"issue":"6","key":"1137_CR34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ana.410320614","volume":"32","author":"M Schulzer","year":"1992","unstructured":"Schulzer M, Mak E, Calne DB (1992) The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic. Ann Neurol 32(6):795\u2013798","journal-title":"Ann Neurol"},{"issue":"2","key":"1137_CR35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1471-4159.1998.70020515.x","volume":"70","author":"IA Paterson","year":"1998","unstructured":"Paterson IA, Zhang D, Warrington RC, Boulton AA (1998) R-deprenyl and R-2-heptyl-N-methylpropargylamine prevent apoptosis in cerebellar granule neurons induced by cytosine arabinoside but not low extracellular potassium. J Neurochem 70(2):515\u2013523","journal-title":"J Neurochem"},{"issue":"3","key":"1137_CR36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neulet.2003.10.019","volume":"354","author":"M Kiray","year":"2004","unstructured":"Kiray M, Uysal N, Sonmez A, Acikgoz O, Gonenc S (2004) Positive effects of deprenyl and estradiol on spatial memory and oxidant stress in aged female rat brains. Neurosci Lett 354(3):225\u2013228","journal-title":"Neurosci Lett"},{"issue":"11","key":"1137_CR37","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1097\/00001756-199808030-00031","volume":"9","author":"T Thomas","year":"1998","unstructured":"Thomas T, McLendon C, Thomas G (1998) L-deprenyl: nitric oxide production and dilation of cerebral blood vessels. NeuroReport 9(11):2595\u20132600","journal-title":"NeuroReport"},{"issue":"2\u20133","key":"1137_CR38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0047-6374(94)01559-5","volume":"79","author":"YC Zeng","year":"1995","unstructured":"Zeng YC, Bongrani S, Bronzetti E, Cadel S, Ricci A, Valsecchi B, Amenta F (1995) Effect of long-term treatment with L-deprenyl on the age-dependent microanatomical changes in the rat hippocampus. Mech Ageing Dev 79(2\u20133):169\u2013185","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"1137_CR39","first-page":"175","volume":"7","author":"K Magyar","year":"1999","unstructured":"Magyar K, Haberle D (1999) Neuroprotective and neuronal rescue effects of selegiline: review. Neurobiology (Bp) 7(2):175\u2013190","journal-title":"Neurobiology (Bp)"},{"issue":"2","key":"1137_CR40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neurobiolaging.2004.04.003","volume":"26","author":"N Pitsikas","year":"2005","unstructured":"Pitsikas N, Rigamonti AE, Cella SG, Sakellaridis N, Muller EE (2005) The nitric oxide donor molsidomine antagonizes age-related memory deficits in the rat. Neurobiol Aging 26(2):259\u2013264","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1137_CR41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/nlme.1995.1011","volume":"63","author":"C Fin","year":"1995","unstructured":"Fin C, da Cunha C, Bromberg E, Schmitz PK, Bianchin M, Medina JH, Izquierdo I (1995) Experiments suggesting a role for nitric oxide in the hippocampus in memory processes. Neurobiol Learn Mem 63(2):113\u2013115","journal-title":"Neurobiol Learn Mem"},{"issue":"8","key":"1137_CR42","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.exger.2004.04.008","volume":"39","author":"P Liu","year":"2004","unstructured":"Liu P, Smith PF, Appleton I, Darlington CL, Bilkey DK (2004) Potential involvement of NOS and arginase in age-related behavioural impairments. Exp Gerontol 39(8):1207\u20131222","journal-title":"Exp Gerontol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-013-1137-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-013-1137-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-013-1137-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T04:33:04Z","timestamp":1563856384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-013-1137-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["1137"],"URL":"https:\/\/doi.org\/10.1007\/s11064-013-1137-6","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]}}}